Clinical Trial Update: IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma [Phase 1]

View source ↗

Summary

Phase 1 trial of ipilimumab-based biochemotherapy in chemonaive patients with metastatic melanoma was terminated. The document notes the status of the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Ipilimumab (Yervoy) (ipilimumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Melanoma | Phase 1 | Status: TERMINATED